Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lentiviral Gene Transfer for XSCID in Patients Older Than 2 Years
NCT01306019Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2012
- Primary completion
- Dec 2032
- Countries
- 1
01
Overview
A Phase 2 trial of MB-117 in X-linked severe combined immunodeficiency (X-SCID), sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2012; status: recruiting.
02
Drugs
MB-117
03
Conditions
X-linked severe combined immunodeficiency (X-SCID)
Beyond the preview
Go deeper on NCT01306019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01306019.